[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global DNA Vaccines Market Professional Survey Report 2016

June 2016 | 114 pages | ID: GC221970B71EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report mainly covers the following

Segment regions including (the separated region report can also be offered)
  • EU
  • USA
  • India
  • Japan
  • China
The players list (Partly, Players you are interested in can also be added)
  • Merck
  • Sanofi?
  • GSK
  • Pfizer
  • Novartis
  • Vical
  • Astellas
  • Dendreon
  • Arbutus Biopharma
With no less than 10 top producers.

Data including (both global and regions): Market Size (both volume - K Doses and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 INDUSTRY OVERVIEW OF DNA VACCINES

1.1 Definition and Specifications of DNA Vaccines
  1.1.1 Definition of DNA Vaccines
  1.1.2 Specifications of DNA Vaccines
1.2 Classification of DNA Vaccines
1.3 Applications of DNA Vaccines
1.4 Industry Chain Structure of DNA Vaccines
1.5 Industry Overview and Major Regions Status of DNA Vaccines
  1.5.1 Industry Overview of DNA Vaccines
  1.5.2 Global Major Regions Status of DNA Vaccines
1.6 Industry Policy Analysis of DNA Vaccines
1.7 Industry News Analysis of DNA Vaccines

2 MANUFACTURING COST STRUCTURE ANALYSIS OF DNA VACCINES

2.1 Raw Material Suppliers and Price Analysis of DNA Vaccines
2.2 Equipment Suppliers and Price Analysis of DNA Vaccines
2.3 Labor Cost Analysis of DNA Vaccines
2.4 Other Costs Analysis of DNA Vaccines
2.5 Manufacturing Cost Structure Analysis of DNA Vaccines
2.6 Manufacturing Process Analysis of DNA Vaccines

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF DNA VACCINES

3.1 Capacity and Commercial Production Date of Global DNA Vaccines Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global DNA Vaccines Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global DNA Vaccines Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global DNA Vaccines Major Manufacturers in 2015

4 GLOBAL DNA VACCINES OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global DNA Vaccines Capacity and Growth Rate Analysis
  4.2.2 2015 DNA Vaccines Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global DNA Vaccines Sales and Growth Rate Analysis
  4.3.2 2015 DNA Vaccines Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global DNA Vaccines Sales Price
  4.4.2 2015 DNA Vaccines Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global DNA Vaccines Gross Margin
  4.5.2 2015 DNA Vaccines Gross Margin Analysis (Company Segment)

5 DNA VACCINES REGIONAL MARKET ANALYSIS

5.1 EU DNA Vaccines Market Analysis
  5.1.1 EU DNA Vaccines Market Overview
  5.1.2 EU 2011-2016E DNA Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 EU 2011-2016E DNA Vaccines Sales Price Analysis
  5.1.4 EU 2015 DNA Vaccines Market Share Analysis
5.2 USA DNA Vaccines Market Analysis
  5.2.1 USA DNA Vaccines Market Overview
  5.2.2 USA 2011-2016E DNA Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 USA 2011-2016E DNA Vaccines Sales Price Analysis
  5.2.4 USA 2015 DNA Vaccines Market Share Analysis
5.3 India DNA Vaccines Market Analysis
  5.3.1 India DNA Vaccines Market Overview
  5.3.2 India 2011-2016E DNA Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 India 2011-2016E DNA Vaccines Sales Price Analysis
  5.3.4 India 2015 DNA Vaccines Market Share Analysis
5.4 Japan DNA Vaccines Market Analysis
  5.4.1 Japan DNA Vaccines Market Overview
  5.4.2 Japan 2011-2016E DNA Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2011-2016E DNA Vaccines Sales Price Analysis
  5.4.4 Japan 2015 DNA Vaccines Market Share Analysis
5.5 China DNA Vaccines Market Analysis
  5.5.1 China DNA Vaccines Market Overview
  5.5.2 China 2011-2016E DNA Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 China 2011-2016E DNA Vaccines Sales Price Analysis
  5.5.4 China 2015 DNA Vaccines Market Share Analysis

6 GLOBAL 2011-2016E DNA VACCINES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E DNA Vaccines Sales by Type
6.2 Different Types DNA Vaccines Product Interview Price Analysis
6.3 Different Types DNA Vaccines Product Driving Factors Analysis

7 GLOBAL 2011-2016E DNA VACCINES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF DNA VACCINES

8.1 Merck
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Merck 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Merck 2015 DNA Vaccines Business Region Distribution Analysis
8.2 Sanofi?
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Sanofi? 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Sanofi? 2015 DNA Vaccines Business Region Distribution Analysis
8.3 GSK
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 GSK 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GSK 2015 DNA Vaccines Business Region Distribution Analysis
8.4 Pfizer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Pfizer 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Pfizer 2015 DNA Vaccines Business Region Distribution Analysis
8.5 Novartis
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Novartis 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Novartis 2015 DNA Vaccines Business Region Distribution Analysis
8.6 Vical
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Vical 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Vical 2015 DNA Vaccines Business Region Distribution Analysis
8.7 Astellas
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Astellas 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Astellas 2015 DNA Vaccines Business Region Distribution Analysis
8.8 Dendreon
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Dendreon 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Dendreon 2015 DNA Vaccines Business Region Distribution Analysis
8.9 Arbutus Biopharma
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Arbutus Biopharma 2015 DNA Vaccines Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Arbutus Biopharma 2015 DNA Vaccines Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 EU 2016-2021 DNA Vaccines Consumption Forecast
  9.2.2 USA 2016-2021 DNA Vaccines Consumption Forecast
  9.2.3 India 2016-2021 DNA Vaccines Consumption Forecast
  9.2.4 Japan 2016-2021 DNA Vaccines Consumption Forecast
  9.2.5 China 2016-2021 DNA Vaccines Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 DNA VACCINES MARKETING MODEL ANALYSIS

10.1 DNA Vaccines Regional Marketing Model Analysis
10.2 DNA Vaccines International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of DNA Vaccines by Regions
10.4 DNA Vaccines Supply Chain Analysis

11 CONSUMERS ANALYSIS OF DNA VACCINES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF DNA VACCINES

12.1 New Project SWOT Analysis of DNA Vaccines
12.2 New Project Investment Feasibility Analysis of DNA Vaccines

13 CONCLUSION OF THE GLOBAL DNA VACCINES MARKET PROFESSIONAL SURVEY REPORT 2016


More Publications